Showing 1 - 20 results of 48 for search 'Maurizio Rossini', query time: 0.04s
Refine Results
-
1
Patients with osteoporosis: children of a lesser god by Giovanni Adami, Maurizio Rossini, Thomas Funck-Brentano, Roland Chapurlat, Elena Tsourdi
Published 2023-02-01
Article -
2
-
3
Risk of fracture in patients with glucocorticoid requiring diseases by Giovanni Adami, Davide Gatti, Angelo Fassio, Alessandro Giollo, Ombretta Viapiana, Maurizio Rossini
Published 2021-04-01
Article -
4
Anti-CCP antibodies and bone by Giovanni Orsolini, Ombretta Viapiana, Maurizio Rossini, Giovanni Adami, Cristian Caimmi, Angelo Fassio, Davide Gatti
Published 2018-04-01
Article -
5
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs) by Giovanni Adami, Angelo Fassio, Francesca Pistillo, Camilla Benini, Ombretta Viapiana, Maurizio Rossini, Davide Gatti
Published 2023-09-01
Article -
6
-
7
-
8
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs) by Giovanni Adami, Angelo Fassio, Davide Gatti, Maurizio Rossini, Ombretta Viapiana, Camilla Benini, Davide Bertelle, Francesca Pistillo
Published 2023-01-01
Article -
9
-
10
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic dise... by Angelo Fassio, Davide Gatti, Davide Bertelle, Elena Fracassi, Giulia Zanetti, Ombretta Viapiana, Maurizio Rossini, Giovanni Adami
Published 2022-09-01
Article -
11
-
12
-
13
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? by Giovanni Orsolini, Giovanni Adami, Maurizio Rossini, Angelo Fassio, Alessandro Giollo, Cristian Caimmi, Luca Idolazzi, Davide Gatti, Ombretta Viapiana
Published 2018-11-01
Article -
14
-
15
Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study by Massimo Varenna, Davide Gatti, Francesca Zucchi, Chiara Crotti, Vania Braga, Giovanni Iolascon, Bruno Frediani, Fabrizio Nannipieri, Maurizio Rossini
Published 2022-12-01
Article -
16
Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study by Massimo Varenna, Vania Braga, Davide Gatti, Giovanni Iolascon, Bruno Frediani, Francesca Zucchi, Chiara Crotti, Fabrizio Nannipieri, Maurizio Rossini
Published 2021-06-01
Article -
17
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? by Giovanni Orsolini, Giovanni Adami, Maurizio Rossini, Angelo Fassio, Alessandro Giollo, Cristian Caimmi, Luca Idolazzi, Davide Gatti, Ombretta Viapiana
Published 2018-10-01
Article -
18
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study by Angelo Fassio, Davide Gatti, Maurizio Rossini, Camilla Benini, Elena Fracassi, Eugenia Bertoldo, Ombretta Viapiana, Stefano Milleri, Matteo Gatti, Giovanni Adami
Published 2021-07-01
Article -
19
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study by Angelo Fassio, Giovanni Adami, Maurizio Rossini, Alessandro Giollo, Cristian Caimmi, Riccardo Bixio, Ombretta Viapiana, Stefano Milleri, Matteo Gatti, Davide Gatti
Published 2020-05-01
Article -
20
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis by Riccardo Bixio, Giovanni Adami, Eugenia Bertoldo, Alessandro Giollo, Andrea Morciano, Davide Bertelle, Giovanni Orsolini, Luca Idolazzi, Maurizio Rossini, Ombretta Viapiana
Published 2022-11-01
Article